Sana Biotechnology shareholders elect all four director nominees and ratify auditor

Sana Biotechnology, Inc.

All four Class I directors elected: Steven D. Harr (147.9M for), Robert L. Rosiello (158.2M for), Michelle Seitz (147.9M for), Patrick Y. Yang (143.7M for).
Ratification of Ernst & Young as independent auditor for FY2025: 180.2M for, 55.8K against, 69.6K abstain.
Broker non-votes of 20.9M shares on director election.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.